Tenax Therapeutics, Inc. TENX
1.81
(0.08)
(4.23%)
as of 25 Sep
- Market cap
- $70.0M
- P/E
- 0.0×
Follow TENX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(44.80%) | (55.64%) | (51.71%) | (59.80%) | |
| (42.77%) | (52.36%) | (49.23%) | (57.02%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(45.03%) | (54.19%) | (50.49%) | (57.10%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.65) | (0.91) | (0.84) | (0.90) | |
Free Cash Flow |
(25.91) | (35.80) | (38.14) | (46.03) | |
| Other line items | |||||
Cash ROIC |
(13.25%) | (18.39%) | (16.34%) | (19.88%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.60 | 0.68 | 0.66 | 0.71 | |
Depreciation/Fixed assets |
0.00 | — | — | — | |
Capex/Depreciation |
0.00 | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.65) | (0.91) | (0.84) | (0.90) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates